Search Results - "DARTOIS, N"

The Efficacy and Safety of Tigecycline in the Treatment of Skin and Skin-Structure Infections: Results of 2 Double-Blind Phase 3 Comparison Studies with Vancomycin-Aztreonam by Grosse, E. J. Ellis, Babinchak, T., Dartois, N., Rose, G., Loh, E.

“…Two phase 3, double-blind studies in hospitalized adults with complicated skin and skin-structure infections (cSSSI) determined the safety and efficacy of…”
Get full text

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study by Florescu, I., Beuran, M., Dimov, R., Razbadauskas, A., Bochan, M., Fichev, G., Dukart, G., Babinchak, T., Cooper, C. A., Ellis-Grosse, E. J., Dartois, N., Gandjini, H.

“…Introduction Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are causing serious nosocomial infections…”
Get full text

Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia: European Experience by Dartois, N., Castaing, N., Gandjini, H., Cooper, A.

“…Tigecycline (TGC), a first-in-class glycylcycline that has been approved for treating complicated skin and skin structure infections and complicated…”
Get full text

PIN12 Epidemiology, Outcomes, and Costs of Hospitalization Due to Pneumonia, Meningitis, and Septicemia in Canada from 2004 to 2010 by Qizilbash, N, Mcneil, S, Ye, J, Gray, S, Zanotti, G, Todd, M, Dartois, N

Get full text

P848 Efficacy of tigecycline (TGC) compared with levofloxacin (LEV) for treating Streptococcus pneumoniae bacteraemia in patients (pts) hospitalised with community-acquired pneumonia (CAP) by Dartois, N, Dukart, G, Cooper, C.A, Castaing, N, Gandjini, H

Get full text

Overview of Tigecycline Efficacy and Safety in the Treatment of Complicated Skin and Skin Structure Infections - A European Perspective by Teras, J., Gardovskis, J., Vaasna, T., Kupcs, U., Pupelis, G., Dukart, G., Dartois, N., Jouve, S., Cooper, A.

“…In a randomized, double-blind, multicenter, multinational, controlled trial, 546 patients with complicated skin and skin structure infections received…”
Get full text

P849 Efficacy of tigecycline versus levofioxacin in patients hospitalised with community-acquired pneumonia: analysis of risk factors by Dartois, N, Dukart, G, Cooper, C, Castaing, N, Gandjini, I, Sarkozy, D

Get full text

Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010) by Casez, P., Fauconnier, J., Jorgensen, L., Gutterman, E.M., Gray, S., Munson, S., Dartois, N., Gaillat, J.

“…This population-based retrospective study quantified the burden of all-cause and pneumococcal pneumonia and meningitis in the Rhône-Alpes region of France from…”
Get full text

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial Data by Babinchak, Timothy, Grosse, Evelyn Ellis, Dartois, Nathalie, Rose, Gilbert M., Loh, Evan

“…This pooled analysis includes 2 phase 3, double-blind trials designed to evaluate the safety and efficacy of tigecycline, versus that of imipenem-cilastatin,…”
Get full text

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae by Vasilev, Krasimir, Reshedko, Galina, Orasan, Remus, Sanchez, Miguel, Teras, Juri, Babinchak, Tim, Dukart, Gary, Cooper, Angel, Dartois, Nathalie, Gandjini, Hassan, Orrico, Russ, Ellis-Grosse, Evelyn

“…Objectives To evaluate the efficacy and safety of tigecycline in patients with selected serious infections caused by resistant Gram-negative bacteria, or…”
Get full text

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam by BREEDT, Johannes, TERAS, Jüri, GARDOVSKIS, Janis, MARITZ, Frans Jacobus, VAASNA, Tiit, ROSS, Douglas Patrick, GIOUD-PAQUET, Martine, DARTOIS, Nathalie, ELLIS-GROSSE, Evelyn J, LOH, Evan

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia by Tanaseanu, Cristina, Bergallo, Carlos, Teglia, Osvaldo, Jasovich, Abel, Oliva, Maria Eugenia, Dukart, Gary, Dartois, Nathalie, Cooper, C. Angel, Gandjini, Hassan, Mallick, Rajiv

“…Abstract Tigecycline (TGC), a glycylcycline, has expanded activity against Gram-positive and Gram-negative, anaerobic, and atypical bacteria. Two phase 3…”
Get full text

Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment by Boutouyrie, P, Bussy, C, Hayoz, D, Hengstler, J, Dartois, N, Laloux, B, Brunner, H, Laurent, S

“…Local pulse pressure (PP) is an independent determinant of carotid artery wall thickness, stronger than mean blood pressure (BP). The present study was…”
Get full text

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections - The European Experience by Fomin, P., Koalov, S., Cooper, A., Babinchak, T., Dartois, N., De Vane, N., Castaing, N., Tellado, J.

“…The polymicrobial nature of complicated intra-abdominal infections makes these infections particularly challenging to treat. The initial selection of…”
Get full text

Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia : European Experience: Tigecycline: European Experience by DARTOIS, N, CASTAING, N, GANDJINI, H, COOPER, A

Get full text

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci : a Phase 3, multicentre, double-blind, randomized study: Tigecycline, a therapeutic option from a new antimicrobial class (the glycylcyclines) in an era of increasing resistance by FLORESCU, I, BEURAN, M, DARTOIS, N, GANDJINI, H, DIMOV, R, RAZBADAUSKAS, A, BOCHAN, M, FICHEV, G, DUKART, G, BABINCHAK, T, COOPER, C. A, ELLIS-GROSSE, E. J

Get full text

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections : Results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam: Antimicrobials and Tigecycline by ELLIS-GROSSE, E. J, BABINCHAK, T, DARTOIS, N, ROSE, G, LOH, E

Get full text

Overview of Tigecycline Efficacy and Safety in the Treatment of Complicated Skin and Skin Structure Infections : A European Perspective: Tigecycline: European Experience by TEARS, J, GARDOVSKIS, J, VAASNA, T, KUPCS, U, PUPELIS, G, DUKART, G, DARTOIS, N, JOUVE, S, COOPER, A

Get full text

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections : The European Experience: Tigecycline: European Experience by FOMIN, P, KOALOV, S, COOPER, A, BABINCHAK, T, DARTOIS, N, DE VANE, N, CASTAING, N, TELLADO, J

Get full text

Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties by Witchitz, Serge, Cohen-Solal, Alain, Dartois, Nathalie, Weisslinger, Nadine, Juste, Karine, Darmon, Jean Yves

“…Treatment with β blockers results in improvement in functional status, and reduces mortality in patients with heart failure. A number of differences in the…”
Get full text